237 related articles for article (PubMed ID: 34965511)
1. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
Rahman MW; Trivedi NU; Bach PB; Mitchell AP
J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
[TBL] [Abstract][Full Text] [Related]
2. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB
Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829
[TBL] [Abstract][Full Text] [Related]
3. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
Jairam V; Yu JB
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
[TBL] [Abstract][Full Text] [Related]
4. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.
Marshall DC; Moy B; Jackson ME; Mackey TK; Hattangadi-Gluth JA
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27389914
[TBL] [Abstract][Full Text] [Related]
5. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
7. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets.
Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM
J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912
[TBL] [Abstract][Full Text] [Related]
8. Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines.
Nguyen AX; Joly-Chevrier M; Nguyen DD; Wu AY
JAMA Ophthalmol; 2023 Apr; 141(4):378-383. PubMed ID: 36928457
[TBL] [Abstract][Full Text] [Related]
9. Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?
Wright K; Meyers DE; Chisamore TM; McInnes MDF; Sismondo S; Gyawali B; Prasad V; Booth CM
JCO Oncol Pract; 2022 Jul; 18(7):e1164-e1169. PubMed ID: 35696634
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
Checketts JX; Sims MT; Vassar M
JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
[TBL] [Abstract][Full Text] [Related]
11. Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.
Mitchell AP; Mishra Meza A; Trivedi NU; Bach PB; Gönen M
Oncologist; 2022 Oct; 27(10):857-863. PubMed ID: 35946837
[TBL] [Abstract][Full Text] [Related]
12. Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018.
Marshall DC; Tarras ES; Rosenzweig K; Yom SS; Hattangadi-Gluth J; Murphy J; Korenstein D; Chimonas S
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):15-25. PubMed ID: 32858112
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
[TBL] [Abstract][Full Text] [Related]
14. Financial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data.
Fleischman W; Ross JS; Melnick ER; Newman DH; Venkatesh AK
Ann Emerg Med; 2016 Aug; 68(2):153-158.e4. PubMed ID: 26973175
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019.
Kamamoto S; Murayama A; Kusumi E; Yoshida M; Saito H; Sawano T; Yamashita E; Tanimoto T; Ozaki A
Pediatr Blood Cancer; 2022 Oct; 69(10):e29891. PubMed ID: 35949170
[TBL] [Abstract][Full Text] [Related]
16. Association between physician characteristics and payments from industry in 2015-2017: observational study.
Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Psychiatrist-Industry Financial Relationship: Insight from the Open Payment Data of Centers for Medicare and Medicaid Services.
Rhee TG; Wilkinson ST
Adm Policy Ment Health; 2020 Jul; 47(4):526-530. PubMed ID: 31916072
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.
Weng JK; Valle LF; Nam GE; Chu FI; Steinberg ML; Raldow AC
JAMA Netw Open; 2019 Jan; 2(1):e187377. PubMed ID: 30681710
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
Horn J; Checketts JX; Jawhar O; Vassar M
JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
[TBL] [Abstract][Full Text] [Related]
20. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
